ACL · ASX

Australian Clinical Labs Ltd (ASX:ACL)

AU$2.78

 -0.02 (-0.714%)
ASX:Live
30/06/2025 04:10:08 PM
HALO Small HALO Ords HALO MQV SMALL HALO MQV HALO Earnings Momentum +4
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

ACL Overview

ACL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Weak

Halo Model

MQV

Very Weak

GARP

Very Weak

MQV Small

Very Weak

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About ACL

Website

N/A

Telephone

Address

Description

Australian Clinical Labs Ltd. engages in the provision of pathology services. It operates through the Pathology segment. The Pathology segment includes pathology/clinical laboratory services provided in Australia. The company was founded in 2015 and is headquartered in Clayton, Australia.

ACL Price Chart

Key Stats

Market Cap

AU$534.18M

PE

17.70

EV/EBITDA

3.1

Dividends Overview

DIV Yield

3.4%

Franking

100%

Ex Dividend Date (est.)

27-Mar-25

Market Data

52 weeks range

Low 2.32 - 3.86

Trade Value (12mth)

AU$1,022,510.00

1 week

3.32%

1 month

-1.75%

YTD

-18.13%

1 year

11.55%

All time high

6.39

Key Fundamentals

EPS 3 yr Growth

-69.70%

EBITDA Margin

26.90%

Operating Cashflow

$160m

Free Cash Flow Return

41.50%

ROIC

6.20%

Interest Coverage

10.90

Quick Ratio

0.60

Other Data

Shares on Issue (Fully Dilluted)

202m

HALO Sector

Next Company Report Date

20-Aug-25

Ex Dividend Date (est.)

27-Mar-25

Next Dividend Pay Date (est.)

16-Apr-25

Reporting Currency

AUD

Short Sell (% of issue)

2.66

ACL Announcements

Latest Announcements

Date Announcements

24 June 25

Becoming a substantial holder from MQG

×

Becoming a substantial holder from MQG

20 June 25

Appointment of new director and chair

×

Appointment of new director and chair

20 June 25

Initial Director's Interest Notice - S Roche

×

Initial Director's Interest Notice - S Roche

19 June 25

Change in substantial holding from MUFG

×

Change in substantial holding from MUFG

18 June 25

Change in substantial holding

×

Change in substantial holding

17 June 25

Notification regarding unquoted securities - ACL

×

Notification regarding unquoted securities - ACL

17 June 25

Notification regarding unquoted securities - ACL

×

Notification regarding unquoted securities - ACL

17 June 25

Notification regarding unquoted securities - ACL

×

Notification regarding unquoted securities - ACL

11 June 25

Change in substantial holding

×

Change in substantial holding

11 June 25

Change in substantial holding

×

Change in substantial holding

05 June 25

Change in substantial holding

×

Change in substantial holding

03 June 25

Change in substantial holding

×

Change in substantial holding

30 May 25

Update - Notification of buy-back - ACL

×

Update - Notification of buy-back - ACL

29 May 25

Update - Notification of buy-back - ACL

×

Update - Notification of buy-back - ACL

27 May 25

Notification of cessation of securities - ACL

×

Notification of cessation of securities - ACL

26 May 25

Update - Notification of buy-back - ACL

×

Update - Notification of buy-back - ACL

23 May 25

Notification of cessation of securities - ACL

×

Notification of cessation of securities - ACL

20 May 25

Update - Notification of buy-back - ACL

×

Update - Notification of buy-back - ACL

16 May 25

Update - Notification of buy-back - ACL

×

Update - Notification of buy-back - ACL

15 May 25

Update - Notification of buy-back - ACL

×

Update - Notification of buy-back - ACL

14 May 25

Change in substantial holding

×

Change in substantial holding

09 May 25

Update - Notification of buy-back - ACL

×

Update - Notification of buy-back - ACL

09 May 25

Change in substantial holding

×

Change in substantial holding

08 May 25

Update - Notification of buy-back - ACL

×

Update - Notification of buy-back - ACL

08 May 25

Notification of cessation of securities - ACL

×

Notification of cessation of securities - ACL

Dividends

Key Stats

Ex Dividend Date (est.)

27-Mar-25

DIV Yield

3.4%

Franking Level

100%

DPSg

-14.30%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

2.66%

Value ($M)

14

Prior Change

N/A

7 Day Change

0.20%

1 Month Change

0.20%

3 Month Change

0.40%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ACL Shortsell

Frequently Asked Questions

The current share price of Australian Clinical Labs Ltd (ACL:ASX) is AU$2.78.
The 52-week high share price for Australian Clinical Labs Ltd (ACL:ASX) is AU$3.86.
The 52-week low share price for Australian Clinical Labs Ltd (ACL:ASX)? is AU$2.32.
The current TTM dividend payout for Australian Clinical Labs Ltd (ACL:ASX) is 3.40.
The last dividend payment of Australian Clinical Labs Ltd (ACL:ASX) is AU$0.04.
Australian Clinical Labs Ltd (ACL:ASX) has a franking level of 100.0%.
Australian Clinical Labs Ltd (ACL:ASX) is classified in the Healthcare.
The current P/E ratio for Australian Clinical Labs Ltd (ACL:ASX) is 17.70.